Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

BioLine RX Ltd (BLRX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
31.8 -0.2    -0.63%
08:49:26 - Closed. Currency in ILS ( Disclaimer )
Type:  Equity
Market:  Israel
ISIN:  IL0011015182 
S/N:  1101518
  • Volume: 315,954
  • Bid/Ask: 32.4 / 32.5
  • Day's Range: 31.1 - 32.6
BioLine RX 31.8 -0.2 -0.63%
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Jun 20, 2022 Vítor Bernardo   31.6 +0.63%
May 29, 2022 Moshe Tvig   32.8 Jun 23, 2022 @ 32.0 -2.44%
May 24, 2022 רמי מימון   28.6 Jun 16, 2022 @ 29.8 +4.20%
May 12, 2022 Zeev Sin   25.3 Jun 02, 2022 @ 33.6 -32.81%
May 11, 2022 סשה בורלק   28.0 Jun 02, 2022 @ 33.6 +20.00%
May 08, 2022 ניב מימון   29.6 Jun 02, 2022 @ 33.6 +13.51%
Apr 27, 2022 Moshe Tvig   32.0 May 19, 2022 @ 29.4 -8.13%
Apr 17, 2022 יוסי אלצטר   33.7 May 12, 2022 @ 24.7 -26.71%
Apr 13, 2022 Zeev Sin   33.8 May 05, 2022 @ 30.2 +10.65%
Apr 12, 2022 Ohad Carmon   35.0 May 05, 2022 @ 30.2 +13.71%
Mar 27, 2022 דוד שמן   37.4 Apr 21, 2022 @ 33.8 -9.63%
Mar 21, 2022 Moshe Tvig   34.5 Apr 21, 2022 @ 33.8 -2.03%
Mar 16, 2022 סשה בורלק   34.4 Apr 07, 2022 @ 36.3 -5.52%
Mar 16, 2022 יריב עירוני   34.3 Apr 07, 2022 @ 36.3 +5.83%
Mar 03, 2022 עופר קלבו   35.6 Mar 24, 2022 @ 34.8 -2.25%
Mar 03, 2022 עופר קלבו   38.0 Mar 03, 2022 @ 37.1 -2.37%
Mar 03, 2022 ניב מימון   38.0 Mar 24, 2022 @ 34.8 -8.42%
Mar 03, 2022 doris abu shkara   39.5 Mar 24, 2022 @ 34.8 -11.90%
Mar 01, 2022 Zeev Sin   34.5 Mar 24, 2022 @ 34.8 -0.87%
Feb 28, 2022 רמי מימון   34.3 Mar 24, 2022 @ 34.8 +1.46%
Feb 08, 2022 Yehuda Yanay   39.3 Mar 03, 2022 @ 35.3 -10.18%
Feb 06, 2022 יריב עירוני   40.0 Mar 03, 2022 @ 35.3 -11.75%
Feb 06, 2022 Moshe Tvig   39.6 Mar 03, 2022 @ 35.3 -10.86%
Feb 03, 2022 itay tuka   37.5 Feb 24, 2022 @ 32.1 +14.40%
Jan 31, 2022 Артем Маеров   39.0 Feb 24, 2022 @ 32.1 -17.69%
Jan 30, 2022 חיים נבון   38.6 Feb 24, 2022 @ 32.1 -16.84%
Jan 24, 2022 אבי דהן   39.1 Feb 17, 2022 @ 38.7 -1.02%
Jan 19, 2022 רמי מימון   46.4 Feb 10, 2022 @ 39.0 -15.95%
Jan 18, 2022 שילה כהן   45.2 Feb 10, 2022 @ 39.0 -13.72%
Jan 18, 2022 aviad bentov   46.5 Feb 10, 2022 @ 39.0 -16.13%
Jan 11, 2022 Zeev Sin   43.7 Feb 03, 2022 @ 38.3 +12.36%
Jan 05, 2022 Moshe Tvig   44.5 Jan 27, 2022 @ 39.4 -11.46%
Jan 02, 2022 ניב מימון   44.1 Jan 27, 2022 @ 39.4 -10.66%
Dec 30, 2021 אריאל כהן   42.8 Jan 20, 2022 @ 43.7 -2.10%
Dec 28, 2021 שלום הבלין   45.4 Jan 20, 2022 @ 43.7 -3.74%
Dec 15, 2021 Levi Lebovits   50.8 Jan 06, 2022 @ 43.7 -13.98%
Dec 12, 2021 Nissim Lambaz   56.5 Jan 06, 2022 @ 43.7 -22.65%
Dec 12, 2021 ירון צברי   55.1 Jan 06, 2022 @ 43.7 +20.69%
Dec 08, 2021 דוד שמן   49.5 Dec 30, 2021 @ 43.2 -12.73%
Dec 07, 2021 רמי מימון   47.0 Dec 30, 2021 @ 43.2 -8.09%
Dec 07, 2021 דוד עזורי   46.3 Dec 12, 2021 @ 55.8 +20.52%
Dec 06, 2021 יוסי אלצטר   47.8 Dec 30, 2021 @ 43.2 -9.62%
Dec 05, 2021 Zeev Sin   48.5 Dec 30, 2021 @ 43.2 +10.93%
Dec 05, 2021 Moshe Tvig   53.4 Dec 30, 2021 @ 43.2 -19.10%
Nov 22, 2021 Alon Demle   55.8 Dec 16, 2021 @ 50.2 -10.04%
Nov 21, 2021 Yaniv Sinai   54.2 Dec 16, 2021 @ 50.2 +7.38%
Nov 07, 2021 Moshe Tvig   59.0 Dec 02, 2021 @ 53.4 -9.49%
Nov 01, 2021 פיני יצחקי   59.1 Nov 25, 2021 @ 54.5 -7.78%
Oct 25, 2021 Zeev Sin   60.8 Nov 18, 2021 @ 56.2 +7.57%
Oct 24, 2021 רמי מימון   60.4 Nov 18, 2021 @ 56.2 -6.95%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BLRX Comments

Write your thoughts about BioLine RX Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email